Intralesional agents in the management of cutaneous malignancy: A review
- 1 February 2011
- journal article
- review article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 64 (2), 413-422
- https://doi.org/10.1016/j.jaad.2009.12.013
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Intralesional methotrexate treatment for keratoacanthoma tumors: A retrospective study and review of the literatureJournal of the American Academy of Dermatology, 2007
- Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapyJournal of the American Academy of Dermatology, 2006
- Treatment of primary cutaneous CD30+ anaplastic large cell lymphoma with intralesional methotrexateJournal of the American Academy of Dermatology, 2006
- Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gelJournal of the American Academy of Dermatology, 1997
- Bleomycin-mediated electrochemotherapy of basal cell carcinomaJournal of the American Academy of Dermatology, 1996
- Large keratoacanthomas treated with intralesional interferon alfa-2aJournal of the American Academy of Dermatology, 1993
- The pharmacology of methotrexateJournal of the American Academy of Dermatology, 1991
- Treatment of neoplastic skin lesions with intralesional interferonJournal of the American Academy of Dermatology, 1989
- Large keratoacanthomas in difficult locations treated with intralesional 5-fiuorouracilJournal of the American Academy of Dermatology, 1986
- Treatment of multiple keratoacanthomas with intralesional fluorouracilJournal of the American Academy of Dermatology, 1982